Zavarovalnica Triglav d.d. (ZVTG) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
21 Aug, 2026Executive summary
Achieved robust growth in Q1 2025, with total business volume up 18% year-over-year to €553.7M, driven by strong premium growth and international expansion.
Earnings before tax (EBT) rose 25% year-over-year to €54.3M, with adjusted EBT up 39% and net earnings up 26% to €46.1M.
Combined ratio for Non-Life and Health segments remained low at 88.5%, indicating sustained profitability.
Confirmed annual profit guidance for 2025, targeting EBT of €130–€150M, and proposed a dividend of €2.80 per share, up 60% year-over-year.
The Group remains well-capitalised, with solvency ratio at 219% and capitalisation within the 200–250% target range.
Financial highlights
Gross written premium rose by 18% to €530.2M year-over-year; total business volume reached €553.7M (+18% YoY).
Insurance operating result up 15% to €40.4M; net investment result up 78% to €9.2M.
Claims incurred increased by 42% to €185.7M, mainly due to portfolio growth and higher CAT claims.
Expense ratio improved to 25.0% (down 1.0 pp YoY); annualised ROE rose to 19.8% (up 2.6 pp YoY).
Return on financial investments (excl. unit-linked) was 2.6% (up 0.6 pp YoY).
Outlook and guidance
Annual profit guidance for 2025 reaffirmed, with planned EBT of €130–€150M and net earnings expected at €100–€120M.
2025 plan targets total business volume above €1.8B and combined ratio below 95%.
Strategic ambition to double EBT to €250–€300M and TBV to €2.5–€3.0B by 2030.
Dividend payouts of approximately €400M planned for 2025–2030.
Focus on internationalization, diversification, and above-average growth outside Slovenia.
Latest events from Zavarovalnica Triglav d.d.
- 2024 saw record EBT, strong segment results, and a positive outlook for growth and profitability.ZVTG
Q4 2024 - Business volume up 36% YoY, profit guidance raised, and international growth accelerates.ZVTG
Q3 2025 - H1 2024 EBT reached EUR 89.5m, with strong Non-Life, improved investments, and a 90.6% combined ratio.ZVTG
Q2 2024 - EBT up 9% YoY to €174.1M, with 49% business volume growth and robust financial stability.ZVTG
Q4 2025 - Business volume up 13% YoY, EBT down 4% to EUR 105.2m amid higher claims; guidance reaffirmed.ZVTG
Q2 2026 - Q1 2026 saw 14% business growth, resilient earnings, and a 7% higher dividend proposal.ZVTG
Q1 2026 - EBT rose to €124.7M in 9M 2024, with upgraded guidance and strong capitalisation.ZVTG
Q3 2024 - Earnings before tax up 22%, profit guidance raised, and credit rating upgraded.ZVTG
Q2 2025